• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.

作者信息

Ito R, Statland B E

出版信息

Clin Chem. 1981 Apr;27(4):586-93.

PMID:6907061
Abstract

The amidolytic activity of activated kallikrein in plasma can be measured by use of the chromogenic substrate, S-2302 (H-D-Pro-Phe-Arg-pNA). Plasma prekallikrein was activated to kallikrein by exposure to 50 mg/L dextran sulfate in acetone/water (35/65 by vol) at 0 degrees C for 15 min. The acetone slows anti-kallikrein activity and increases the kallikrein activity by 30%. The 37 degrees C reaction mixture contained 0.54 mmol of S-2302 substrate per liter of Tris buffer (pH 7.5 at 37 degrees C). We monitored the change in absorbance at 405 nm for 60 s. The specificity of the substrate for kallikrein was demonstrated by using plasma deficient in prekallikrein (Fletcher trait) diluted with pooled normal human plasma. We recommend collecting blood specimens with sodium citrate as the anticoagulant and with use of a double-syringe technique and all-plastic containers. Plasma kallikrein activity with Chromozym-PK (Bz-Pro-Phe-Arg-pNA) as substrate (y-axis) compared with S-2302 as substrate (x-axis) gave the relation: y = 0.28x + 0.82 (r = 0.94). Day-to-day analytical variation was 2.4% for a pooled plasma with a mean value of 85.9 mukat/L. The mean (and 2 SD) for 50 healthy adults was 86.4 (32.4) mukat/L.

摘要

相似文献

1
Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
Clin Chem. 1981 Apr;27(4):586-93.
2
Assaying plasma prekallikrein (PPK) by a chromogenic based method: analytical considerations and reference values in healthy adults, the pregnant woman, and the neonate.采用基于显色法检测血浆前激肽释放酶(PPK):健康成年人、孕妇及新生儿的分析考量与参考值
Adv Exp Med Biol. 1983;156:205-23.
3
Autoactivation of human plasma prekallikrein.
J Biol Chem. 1987 Aug 15;262(23):11308-14.
4
[The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
Vopr Med Khim. 1989 Mar-Apr;35(2):128-33.
5
[Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].[应用显色底物评估肾病综合征患者血浆中激肽释放酶-激肽系统和凝血系统指标]
Vopr Med Khim. 1983 Sep-Oct;29(5):96-9.
6
Mechanized assay of plasma prekallikrein by activation with Pseudomonas aeruginosa elastase and amidolysis of chromogenic substrate.通过铜绿假单胞菌弹性蛋白酶激活和显色底物酰胺水解对血浆前激肽释放酶进行机械化测定。
Clin Chim Acta. 1991 Aug 30;200(2-3):119-27. doi: 10.1016/0009-8981(91)90083-o.
7
Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.丝氨酸蛋白酶抑制剂对活化接触因子的作用研究。在凝血因子XIIa、血浆激肽释放酶和凝血因子XIa的酰胺水解测定中的应用。
Eur J Biochem. 1987 May 4;164(3):637-42. doi: 10.1111/j.1432-1033.1987.tb11174.x.
8
A novel chromogenic peptide for prekallikrein/kallikrein determination.一种用于检测前激肽释放酶/激肽释放酶的新型显色肽。
Clin Lab. 2009;55(3-4):106-13.
9
Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.人、牛和兔血浆中的前激肽释放酶激活:牛血浆中存在一种抑制剂。
Inflammation. 1992 Jun;16(3):205-13. doi: 10.1007/BF00918810.
10
Diagnostic ultrasound activates pure prekallikrein.
Blood Coagul Fibrinolysis. 2012 Dec;23(8):781-3. doi: 10.1097/MBC.0b013e328358e8c3.

引用本文的文献

1
ITIH4 and Gpx3 are potential biomarkers for amyotrophic lateral sclerosis.ITIH4 和 Gpx3 是肌萎缩侧索硬化症的潜在生物标志物。
J Neurol. 2013 Jul;260(7):1782-97. doi: 10.1007/s00415-013-6877-3. Epub 2013 Feb 23.
2
Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.激肽释放酶抑制剂可限制大鼠中缓激肽B(2)拮抗剂诱导的水肿性胰腺炎向出血性胰腺炎的进展。
Br J Pharmacol. 2008 Nov;155(6):865-74. doi: 10.1038/bjp.2008.321. Epub 2008 Aug 11.
3
Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
大鼠实验性急性胰腺炎期间激肽释放的机制:水肿形成的促炎及抗炎作用的证据
Br J Pharmacol. 2003 May;139(2):299-308. doi: 10.1038/sj.bjp.0705247.
4
Involvement of tissue kallikrein but not plasma kallikrein in the development of symptoms mediated by endogenous kinins in acute pancreatitis in rats.组织激肽释放酶而非血浆激肽释放酶参与大鼠急性胰腺炎内源性激肽介导的症状发展过程。
Br J Pharmacol. 2002 Nov;137(5):692-700. doi: 10.1038/sj.bjp.0704910.